Eterna Therapeutics logo

Eterna Therapeutics share price today

(ERNA)

Eterna Therapeutics share price is $0.25 & ₹21.24 as on 21 Dec 2024, 2.30 'hrs' IST

$0.25

Market is closed - opens 8 PM, 23 Dec 2024

View live Eterna Therapeutics share price in Dollar and Rupees. Guide to invest in Eterna Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Eterna Therapeutics. Get details on the Indian mutual funds that are investing in Eterna Therapeutics. Get Analyst recommendations and forecasts along with all the Eterna Therapeutics's financials.

Eterna Therapeutics share price movements

  • Today's Low: $0.24
    Today's High: $0.26

    Day's Volatility :8.81%

  • 52 Weeks Low: $0.22
    52 Weeks High: $2.63

    52 Weeks Volatility :91.57%

Eterna Therapeutics Returns

PeriodEterna Therapeutics IncIndex (Russel 2000)
3 Months
-79.5%
0.0%
6 Months
-86.48%
0.0%
1 Year
-86.63%
0.0%
3 Years
-94.86%
-19.7%

Eterna Therapeutics Key Statistics

in dollars & INR

Previous Close
$0.2475
Open
$0.243
Today's High
$0.2632
Today's Low
$0.24
Market Capitalization
$12.7M
Today's Volume
$371.4K
52 Week High
$2.625
52 Week Low
$0.2212
Revenue TTM
$162.0K
EBITDA
$-21.9M
Earnings Per Share (EPS)
$-8.31
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1154.18%

How to invest in Eterna Therapeutics from India?

It is very easy for Indian residents to invest directly in Eterna Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Eterna Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Eterna Therapeutics or ERNA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Eterna Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Eterna Therapeutics shares which would translate to 3.399 fractional shares of Eterna Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Eterna Therapeutics, in just a few clicks!

Returns in Eterna Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Eterna Therapeutics investment value today

Current value as on today

₹1,88,827

Returns

₹88,827

(+88.83%)

Returns from Eterna Therapeutics Stock

₹86,631 (false-86.63%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Eterna Therapeutics

29%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Eterna Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 29% more investors are searching Eterna Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Eterna Therapeutics

  • CI Private Wealth LLC

    0.51%

  • Cypress Point Wealth Management, LLC

    0.18%

  • UBS Group AG

    0.16%

  • Naviter Wealth, LLC

    0.15%

  • Sippican Capital Adivsors

    0.13%

  • TWO SIGMA SECURITIES, LLC

    0.06%

Analyst Recommendation on Eterna Therapeutics

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Eterna Therapeutics(by analysts ranked 0 to 5 stars)

Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
3
3
3

Analyst Forecast on Eterna Therapeutics

What analysts predicted

Upside of 1100.0%

Current:

$0.25

Target:

$3.00

Insights on Eterna Therapeutics

  • Price Movement

    In the last 7 days, ERNA stock has moved down by -13.5%
  • ERNA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 120.9%
  • ERNA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 118.0%
  • Price to Sales

    ForERNA every $1 of sales, investors are willing to pay $8.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Eterna Therapeutics Technicals Summary

Sell

Neutral

Buy

Eterna Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Eterna Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Eterna Therapeutics Inc
-53.01%
-86.48%
-86.63%
-94.86%
-94.83%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Eterna Therapeutics Inc
NA
NA
NA
0.0
-11.54
-0.29
NA
0.41
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Eterna Therapeutics Inc
Sell
$12.7M
-94.83%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Eterna Therapeutics

brooklyn is focused on exploring the role that cytokine, gene editing, and cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases. brooklyn’s most advanced program is irx-2, a human cell-derived cytokine therapy, studying the safety and efficacy of irx-2 in patients with head and neck cancer in phase 2b. in a phase 2a clinical trial in head and neck cancer, irx-2 demonstrated an overall survival benefit. additional studies are either underway or planned in other solid tumor cancer indications. brooklyn has multiple next-generation cell and gene-editing therapies in preclinical development for various indications including acute respiratory distress syndrome, solid tumor indications, as well as in vivo gene-editing therapies for rare genetic diseases. for more information about brooklyn and its clinical programs, please visit www.brooklynitx.com.
Organization
Eterna Therapeutics
Employees
8
CEO
Ms. Sandra M. Gurrola
Industry
Healthcare

Management People of Eterna Therapeutics

NameTitle
Ms. Sandra M. Gurrola
Principal Financial & Accounting Officer and Senior VP of Finance
Mr. Sanjeev Luther
CEO, President & Director
Dr. Robert Hamilton Pierce M.D.
Chief Scientific Officer
Ms. Dorothy J. Clarke
General Counsel & Director

Important FAQs about investing in Eterna Therapeutics from India :

What is Eterna Therapeutics share price today?

Eterna Therapeutics share price today stands at $0.25, Open: $0.24 ; Previous Close: $0.25 ; High: $0.26 ; Low: $0.24 ; 52 Week High: $2.63 ; 52 Week Low: $0.22. The stock opens at $0.24, after a previous close of $0.25. The stock reached a daily high of $0.26 and a low of $0.24, with a 52-week high of $2.63 and a 52-week low of $0.22.

Can Indians buy Eterna Therapeutics shares?

Yes, Indians can invest in the Eterna Therapeutics (ERNA) from India.

With INDmoney, you can buy Eterna Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Eterna Therapeutics at zero transaction cost.

How can I buy Eterna Therapeutics shares from India?

It is very easy to buy Eterna Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Eterna Therapeutics be purchased?

Yes, you can buy fractional shares of Eterna Therapeutics with INDmoney app.

What are the documents required to start investing in Eterna Therapeutics stocks?

To start investing in Eterna Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Eterna Therapeutics

Today’s highest price of Eterna Therapeutics (ERNA) is $0.26.

Today’s lowest price of Eterna Therapeutics (ERNA) is $0.24.

What is today's market capitalisation of Eterna Therapeutics

Today's market capitalisation of Eterna Therapeutics ERNA is 12.7M

What is the 52 Week High and Low Range of Eterna Therapeutics

  • 52 Week High

    $2.63

  • 52 Week Low

    $0.22

What are the historical returns of Eterna Therapeutics?

  • 1 Month Returns

    -53.01%

  • 3 Months Returns

    -86.48%

  • 1 Year Returns

    -86.63%

  • 5 Years Returns

    -94.83%

Who is the Chief Executive Officer (CEO) of Eterna Therapeutics

Ms. Sandra M. Gurrola is the current Chief Executive Officer (CEO) of Eterna Therapeutics.